| Republicans fail again to kill off Obamacare in Senate | | | WASHINGTON (Reuters) - U.S. Republicans on Tuesday fell short yet again in their seven-year drive to repeal Obamacare, in a bitter defeat that raises more questions about their ability to enact President Donald Trump's agenda. |
| |
| Senators want probe of Allergan transfer deal with tribe: letter | | | (Reuters) - Four U.S. senators have asked the Senate Judiciary Committee to launch an investigation into a deal drugmaker Allergan Plc struck with a Native American tribe to protect some of its patents from generic challenge, according to a letter seen by Reuters. |
| |
| Merck KGaA eyes up to 700 million eur Mavenclad sales in EU | | | FRANKFURT (Reuters) - Germany's Merck KGaA is eyeing annual sales of its multiple sclerosis pill Mavenclad, a late-comer to the market for oral treatments against the neurological disease, of up to 700 million euros ($823 million) in the European Union. |
| |
| Trump 'not happy' with U.S. health chief Price over private travel | | | WASHINGTON (Reuters) - U.S. President Donald Trump said on Wednesday he was "not happy" with Health and Human Services Secretary Tom Price over reports he used expensive private charter jets to travel for government business rather than cheaper commercial flights. |
| |
| FDA approves Abbott's blood glucose monitoring device | | | (Reuters) - The U.S. Food and Drug Administration said it approved Abbott Laboratories' glucose monitoring device for adults with diabetes, allowing millions of people to track their blood sugar levels without having to prick their fingers. |
| |
| | |
